AV-PHOS 250 NEUTRAL - sodium phosphate, dibasic, anhydrous, potassium phosphate, monobasic, and sodium phosphate, monobasic, mon Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

av-phos 250 neutral - sodium phosphate, dibasic, anhydrous, potassium phosphate, monobasic, and sodium phosphate, monobasic, mon

avkare, inc. - sodium phosphate, dibasic, anhydrous (unii: 22ado53m6f) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), potassium phosphate, monobasic (unii: 4j9fj0hl51) (phosphate ion - unii:nk08v8k8hr, potassium cation - unii:295o53k152), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37) - sodium phosphate, dibasic, anhydrous 852 mg - as a phosphorus supplement, each tablet supplies 25% of the u.s. recommended daily allowance (u.s. rda) of phosphorus for adults and children over 4 years of age. av-phos 250 neutral increases urinary phosphate and pyrophosphate. this product is contraindicated in patients with infected phosphate stones in the urinary tract, in patients with severely impaired renal function (less than 30% of normal) and in the presence of hyperphosphatemia.

VIRT-PHOS 250 NEUTRAL- sodium phosphate, dibasic, anhydrous, potassium phosphate, monobasic, and sodium phosphate, monobasic, mo Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

virt-phos 250 neutral- sodium phosphate, dibasic, anhydrous, potassium phosphate, monobasic, and sodium phosphate, monobasic, mo

virtus pharmaceuticals - sodium phosphate, dibasic, anhydrous (unii: 22ado53m6f) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), potassium phosphate, monobasic (unii: 4j9fj0hl51) (phosphate ion - unii:nk08v8k8hr, potassium cation - unii:295o53k152), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37) - sodium phosphate, dibasic, anhydrous 852 mg - as a phosphorus supplement, each tablet supplies 25% of the u.s. recommended daily allowance (u.s. rda) of phosphorus for adults and children over 4 years of age. virt-phos 250 neutral increases urinary phosphate and pyrophosphate. this product is contraindicated in patients with infected phosphate stones in the urinary tract, in patients with severely impaired renal function (less than 30% of normal) and in the presence of hyperphosphatemia.

PHOSPHO-SODA oral solution bottle Australija - engleski - Department of Health (Therapeutic Goods Administration)

phospho-soda oral solution bottle

chiesi australia pty ltd - dibasic sodium phosphate, quantity: 4.3 g; monobasic sodium phosphate, quantity: 18.8 g - oral liquid - excipient ingredients: glycerol; saccharin sodium; sodium benzoate; purified water; flavour - for use as part of a bowel cleansing regimen in preparing adult patients for colon surgery or for preparing the colon for x-ray or endoscopic examination.

CELESTONE CHRONODOSE betamethasone 5.7 mg/1 mL (as acetate and sodium phosphate) injection ampoule Australija - engleski - Department of Health (Therapeutic Goods Administration)

celestone chronodose betamethasone 5.7 mg/1 ml (as acetate and sodium phosphate) injection ampoule

organon pharma pty ltd - betamethasone acetate, quantity: 3 mg/ml (equivalent: betamethasone, qty 5.7 mg/ml); betamethasone sodium phosphate, quantity: 3.9 mg/ml - injection, suspension - excipient ingredients: disodium edetate; monobasic sodium phosphate; water for injections; dibasic sodium phosphate; benzalkonium chloride - celestone chronodose is indicated in the treatment of both severe and moderate conditions in acute and chronic self-limiting diseases responsive to systemic corticosteroid therapy and is especially useful in patients for whom treatment with oral corticosteroid medication is not feasible. representative conditions: rheumatic disorders: rheumatoid arthritis, acute and subacute bursitis, epicondylitis, acute non-specific tenosynovitis, myositis, fibrositis, tendonitis, psoriatic arthritis. collagen diseases: systemic lupus erythematosus, scleroderma, dermatomyositis. allergic states: status asthmaticus, chronic bronchial asthma, seasonal or perennial allergic rhinitis, severe allergic bronchitis, contact dermatitis, atopic dermatitis, hypersensitivity reactions to drug and insect bites. dermatologic conditions: localised, hypertrophic infiltrated lesions of lichen planus, psoriatic plaques, granuloma annulare and lichen simplex chronicus(neurodermatitis). keloids, discoid lupus erythematosus, necrobiosis lipoidi

ORAL SALINE LAXATIVE- dibasic sodium phosphate, monobasic sodium phosphate liquid Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

oral saline laxative- dibasic sodium phosphate, monobasic sodium phosphate liquid

walgreen co - sodium phosphate, dibasic (unii: gr686lba74) (phosphate ion - unii:nk08v8k8hr), sodium phosphate, monobasic (unii: 3980jih2sw) (phosphate ion - unii:nk08v8k8hr) - saline laxative

PREDNISOLONE SODIUM PHOSPHATE solution/ drops Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

prednisolone sodium phosphate solution/ drops

butler animal health supply - prednisolone sodium phosphate (unii: iv021nxa9j) (prednisolone - unii:9phq9y1olm) - prednisolone sodium phosphate 10 mg in 1 ml - prednisolone sodium phosphate ophthalmic solution 1% or 1/8% is for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe, such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitis when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation, corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies. prednisolone sodium phosphate ophthalmic solution, 1%, is recommended for moderate to severe inflammations, particularly when unusually rapid control is desired. in stubborn cases of anterior segment eye disease, systemic adrenocortical hormone therapy may be required. when deeper ocular structures are involved, systemic therapy is necessary. the use of this preparation is contraindicated in the presence of: 1] acute superficial herpes simplex ke

Phosphate Phebra Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

phosphate phebra

phebra nz limited - monobasic sodium phosphate 1.936 g equivalent to to 500 mg phosphorus - effervescent tablet - 500 mg - active: monobasic sodium phosphate 1.936 g equivalent to to 500 mg phosphorus excipient: citric acid confectioner's sugar macrogol 4000 orange concentrate firmenich potassium bicarbonate saccharin sodium sodium bicarbonate - treatment of high blood calcium caused by overactive parathyroid glands or a cancer of the blood (multiple myelomatosis) and other cancers.

PEDIA-LAX- sodium phosphate, dibasic and sodium phosphate, monobasic enema Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

pedia-lax- sodium phosphate, dibasic and sodium phosphate, monobasic enema

c.b. fleet company, inc. - sodium phosphate, dibasic, heptahydrate (unii: 70wt22sf4b) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), sodium phosphate, monobasic (unii: 3980jih2sw) (sodium cation - unii:lyr4m0nh37, phosphate ion - unii:nk08v8k8hr) - sodium phosphate, dibasic, heptahydrate 3.5 g in 66 ml - saline laxative saline laxative for relief of occasional constipation.

QUALITY CHOICE SINGLE SALINE LAXATIVE- sodium phosphate, dibasic and sodium phosphate, monobasic, unspecified form enema Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

quality choice single saline laxative- sodium phosphate, dibasic and sodium phosphate, monobasic, unspecified form enema

cdma - sodium phosphate, dibasic, unspecified form (unii: gr686lba74) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), sodium phosphate, monobasic, unspecified form (unii: 3980jih2sw) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37) - sodium phosphate, dibasic 7 g in 118 ml - - relieves occasional constipation - this product generally produces bowel movement in 1 to 5 minutes

HEALTHMART SALINE SINGLE LAXATIVE- sodium phosphate, dibasic and sodium phosphate, monobasic, unspecified form enema Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

healthmart saline single laxative- sodium phosphate, dibasic and sodium phosphate, monobasic, unspecified form enema

strategic sourcing services llc - sodium phosphate, dibasic, unspecified form (unii: gr686lba74) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), sodium phosphate, monobasic, unspecified form (unii: 3980jih2sw) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37) - sodium phosphate, dibasic 7 g in 118 ml - - relieves occasional constipation - this product generally produces bowel movement in 1 to 5 minutes